Integrative Modeling Strategies for Predicting Drug Toxicities at the eTOX Project

Early prediction of safety issues in drug development is at the same time highly desirable and highly challenging. Recent advances emphasize the importance of understanding the whole chain of causal events leading to observable toxic outcomes. Here we describe an integrative modeling strategy based on these ideas that guided the design of eTOXsys, the prediction system used by the eTOX project. Essentially, eTOXsys consists of a central server that marshals requests to a collection of independent prediction models and offers a single user interface to the whole system. Every of such model lives in a self‐contained virtual machine easy to maintain and install. All models produce toxicity‐relevant predictions on their own but the results of some can be further integrated and upgrade its scale, yielding in vivo toxicity predictions. Technical aspects related with model implementation, maintenance and documentation are also discussed here. Finally, the kind of models currently implemented in eTOXsys is illustrated presenting three example models making use of diverse methodology (3D‐QSAR and decision trees, Molecular Dynamics simulations and Linear Interaction Energy theory, and fingerprint‐based QSAR).

[1]  Khaled Bouri,et al.  Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012. , 2014, JAMA.

[2]  Z Hruban,et al.  Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. , 1984, Environmental health perspectives.

[3]  Ferran Sanz,et al.  The eTOX Data-Sharing Project to Advance in Silico Drug-Induced Toxicity Prediction , 2014, International journal of molecular sciences.

[4]  Kiyohiko Sugano,et al.  Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential. , 2006, The Journal of toxicological sciences.

[5]  Hugh A Barton,et al.  Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment. , 2013, Regulatory toxicology and pharmacology : RTP.

[6]  Chris Oostenbrink,et al.  Improved ligand-protein binding affinity predictions using multiple binding modes. , 2010, Biophysical journal.

[7]  Ferran Sanz,et al.  eTOXlab, an open source modeling framework for implementing predictive models in production environments , 2015, Journal of Cheminformatics.

[8]  Olivier Taboureau,et al.  Virtual Screening and Prediction of Site of Metabolism for Cytochrome P450 1A2 Ligands , 2009, J. Chem. Inf. Model..

[9]  Araz Jakalian,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .

[10]  Pantelis Sopasakis,et al.  Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.

[11]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[12]  Nigel Greene,et al.  Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space. , 2014, Chemical research in toxicology.

[13]  S. Pickett,et al.  GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.

[14]  Manuel Pastor,et al.  Development and Validation of AMANDA, a New Algorithm for Selecting Highly Relevant Regions in Molecular Interaction Fields , 2008, J. Chem. Inf. Model..

[15]  J. Aqvist,et al.  A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.

[16]  J. Schellens,et al.  Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Floriane Montanari,et al.  BCRP Inhibition: from Data Collection to Ligand‐Based Modeling , 2014, Molecular informatics.

[18]  Ruili Huang,et al.  The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.

[19]  M. Cases,et al.  Inroads to Predict in Vivo Toxicology—An Introduction to the eTOX Project , 2012, International journal of molecular sciences.

[20]  Ferran Sanz,et al.  A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity , 2011, J. Chem. Inf. Model..

[21]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[22]  Ferran Sanz,et al.  Applicability Domain Analysis (ADAN): A Robust Method for Assessing the Reliability of Drug Property Predictions , 2014, J. Chem. Inf. Model..

[23]  Akbar Nayeem,et al.  A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series. , 2005, Bioorganic & medicinal chemistry letters.

[24]  Chris Oostenbrink,et al.  CYP 2D6 Binding Affinity Predictions Using Multiple Ligand and Protein Conformations , 2013, International journal of molecular sciences.

[25]  Antti Poso,et al.  Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. , 2005, Journal of medicinal chemistry.

[26]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[27]  Olga Tcheremenskaia,et al.  New perspectives in toxicological information management, and the role of ISSTOX databases in assessing chemical mutagenicity and carcinogenicity. , 2013, Mutagenesis.

[28]  Ralph Kühne,et al.  The OSIRIS Weight of Evidence approach: ITS for the endpoints repeated-dose toxicity (RepDose ITS). , 2013, Regulatory toxicology and pharmacology : RTP.

[29]  J. Kramer,et al.  The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.

[30]  René Meier,et al.  ParaDockS: A Framework for Molecular Docking with Population-Based Metaheuristics , 2010, J. Chem. Inf. Model..

[31]  Mathieu Vinken,et al.  The adverse outcome pathway concept: a pragmatic tool in toxicology. , 2013, Toxicology.

[32]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[33]  J. Sutherland,et al.  A comparison of methods for modeling quantitative structure-activity relationships. , 2004, Journal of medicinal chemistry.

[34]  Loriano Storchi,et al.  New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..

[35]  David M. Reif,et al.  Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.

[36]  Jozef Hritz,et al.  Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking. , 2008, Journal of medicinal chemistry.

[37]  Annette Kopp-Schneider,et al.  Design of a testing strategy using non-animal based test methods: lessons learnt from the ACuteTox project. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[38]  David Raunig,et al.  In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[39]  Daan P. Geerke,et al.  Towards Automated Binding Affinity Prediction Using an Iterative Linear Interaction Energy Approach , 2014, International journal of molecular sciences.

[40]  Wim F Vranken,et al.  ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.

[41]  Naomi L Kruhlak,et al.  Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models , 2008, Toxicology mechanisms and methods.

[42]  Loriano Storchi,et al.  Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical Databases , 2009, J. Chem. Inf. Model..